Aier Eye invests $18.2m in Tianjin subsidiary expansion

Aier Eye Hospital Group (SZSE:300015) is significantly increasing its investment in its Tianjin operations through several strategic moves, as detailed in a series of announcements. First, Aier Eye is increasing its capital in its wholly-owned subsidiary, Tianjin Aier Eye Hospital, by RMB 130 million (approximately $18.2 million USD). This investment aims to increase Tianjin Aier Eye Hospital’s stake in Tianjin Liangjing Medical Management Co., Ltd., a company whose primary asset is land acquired for the expansion and relocation of Tianjin Aier’s facilities. This will bring Tianjin Aier’s shareholding in Liangjing to 92.86%.